issued
on 27 Feb 2024
Last Applicant/ Owned by
3929 Point Eden Way
Hayward
CA
94545
Serial Number
97649707 filed on 26th Oct 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical drug discovery and development services; Scientific and medical research, development and information services in the fields of pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicine discovery and development; Drug discovery and pharmaceutical development services for the pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicinRead More
Pharmaceutical drug discovery and development services; Scientific and medical research, development and information services in the fields of pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicine discovery and development; Drug discovery and pharmaceutical development services for the pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine industries; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for drug discovery and development; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine discovery and development services; Drug, pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine research and development and testing; Research and development of new products in the fields of drugs, pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicines; Biomedical research and development services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Medical and clinical research and pharmaceutical development services to discover and develop medicines and vaccines in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Research, development, analysis, testing and consulting services in the fields of biochemistry, biotechnology, medicines, diagnostics, vaccines and pharmaceuticals; Scientific, medical, biological, biotechnology, biomedical, pharmaceutical research, development, analysis and testing services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Scientific laboratory services, namely, live cell imaging analysis; Custom design and development of cells, cell lines and assays; Biomedical research services using a platform of biological tools and techniques for use in scientific research, drug and vaccine discovery and development; Providing a website featuring information in the fields of drug discovery and development, biochemistry, biotechnology, medicines, diagnostics, and pharmaceuticals; Provision of scientific, medical, biotechnology, biomedical, vaccine and pharmaceutical information regarding drug discovery, pharmaceutical products, vaccines and clinical trials; Providing a website featuring technology that allows users to conduct drug discovery and development; Providing a website featuring technology that allows users to track and measure movement of proteins in living cells
Pharmaceutical preparations comprising small molecules, biologics being biopharmaceuticals, and biologically active substances for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; vaccines; pharmaceutical preparations for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; biopharmaceuticals in the nature of pharmaceutical preparations for the prevention and treatment of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; therapeutic pharmaceuticals for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; diagnostic substances, preparations, and agents for medical purposes
No 97649707
No Service Mark
No 014711-0618
No
No
No
No
No
No
No
No
26.01.02 -
Plain single line circles
26.01.03 -
Incomplete circles (more than semi-circles)
26.01.20 -
Circles within a circle
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
26.05.03 -
Incomplete triangles (must have two angles)
26.05.13 -
Two Triangles
26.05.28 -
Miscellaneous designs with overall triangular shape
The mark consists of a design of a circle that contains four connected lines, one of which extends past the outside of the circle. The lines form one incomplete triangle and one complete triangle. At the end of each line is a small shaded circle.
| Status Date | Action Taken |
|---|---|
| 27th Feb 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 02th Jan 2024 | PUBLISHED FOR OPPOSITION |
| 02th Jan 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 13th Dec 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 27th Nov 2023 | EXAMINERS AMENDMENT -WRITTEN |
| 27th Nov 2023 | EXAMINERS AMENDMENT E-MAILED |
| 27th Nov 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 27th Nov 2023 | EXAMINER'S AMENDMENT ENTERED |
| 27th Nov 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 29th Aug 2023 | NON-FINAL ACTION WRITTEN |
